Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in -3

Ted in blue and purple are shown. The sample represented in purple contains according to the intergrated software a 45% to 55% ratio of mutant and wild type infection respectively. The sample represented in blue shows the opposite pattern and contains 55% to 45% mutant and wild type infection respectively. This can also be seen in the figure by the difference in peak hight. The red curves are the positive controls for wild type strains and the green for mutant strains. The blue horizontal line represents the threshold for background fluorescence, and the curve entirely below shows the results for the negative control (gray).<p><b>Copyright information:</b></p><p>Taken from "Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in "</p><p>http://www.malariajournal.com/content/7/1/48</p><p>Malaria Journal 2008;7():48-48.</p><p>Published online 17 Mar 2008</p><p>PMCID:PMC2276220.</p><p></p

Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in -0

In green the melt curve profile (in triplicate) of mutant clone PS-Peru is shown with a Tm of of 51.9°C. The change in amount of fluorescence for each probe-template hybrid was plotted against the temperature and its negative derivative appeared as a positive peak. The grey lines represent the negative controles.<p><b>Copyright information:</b></p><p>Taken from "Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in "</p><p>http://www.malariajournal.com/content/7/1/48</p><p>Malaria Journal 2008;7():48-48.</p><p>Published online 17 Mar 2008</p><p>PMCID:PMC2276220.</p><p></p

Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in -1

Ted in blue and purple are shown. The sample represented in purple contains according to the intergrated software a 45% to 55% ratio of mutant and wild type infection respectively. The sample represented in blue shows the opposite pattern and contains 55% to 45% mutant and wild type infection respectively. This can also be seen in the figure by the difference in peak hight. The red curves are the positive controls for wild type strains and the green for mutant strains. The blue horizontal line represents the threshold for background fluorescence, and the curve entirely below shows the results for the negative control (gray).<p><b>Copyright information:</b></p><p>Taken from "Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in "</p><p>http://www.malariajournal.com/content/7/1/48</p><p>Malaria Journal 2008;7():48-48.</p><p>Published online 17 Mar 2008</p><p>PMCID:PMC2276220.</p><p></p

Common adverse events by exposure group.

<p><i>U = Unlikely related, D = Definitely unrelated, P = Possibly related; IUFD = Intrauterine Foetal death;</i></p>§<p><i>Mainly mild/moderate severity; PROM = Premature rupture of membranes.</i></p

Overall Pregnancy outcomes by exposure group.

§<p><i>Live births including one set of twins;</i></p><p><i>**Live births only;</i></p><p><i>*Full-term normal deliveries = spontaneous vaginal deliveries at gestational age ≥37 completed weeks; N/A-Not applicable.</i></p

Trial Profile.

<p>Trial Profile.</p

Birth-weight profiles across the exposure groups.

<p><i>**Live births only;</i></p><p><i>SD = Standard deviation.</i></p

Study Design.

<p>Study Design.</p